Global Pregabalin API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pregabalin API Industry Forecast” looks at past sales and reviews total world Pregabalin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pregabalin API sales for 2023 through 2029. With Pregabalin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pregabalin API industry.
This Insight Report provides a comprehensive analysis of the global Pregabalin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pregabalin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pregabalin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pregabalin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pregabalin API.
The global Pregabalin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pregabalin API players cover SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pregabalin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pregabalin API market?
What factors are driving Pregabalin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pregabalin API market opportunities vary by end market size?
How does Pregabalin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pregabalin API Industry Forecast” looks at past sales and reviews total world Pregabalin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pregabalin API sales for 2023 through 2029. With Pregabalin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pregabalin API industry.
This Insight Report provides a comprehensive analysis of the global Pregabalin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pregabalin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pregabalin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pregabalin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pregabalin API.
The global Pregabalin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pregabalin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pregabalin API players cover SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pregabalin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Purity ?99%
- Purity ?99.5%
- Tablet
- Capsule
- Oral Liquid
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- SUANFARMA
- VASUDHA PHARMA
- Atom Pharma
- Sienna Biotec
- Kopran
- Teva
- Afton Pharma
- Cadila
- Sunshine Pharmaceutical
- Hanmi Fine Chemical
- Rivocean Jiangsu Pharmaceutical
- Hubei Vanz Pharm
- Menovo
- Saintsun
- SyncoZymes
- Taian Aidi Biotechnology
What is the 10-year outlook for the global Pregabalin API market?
What factors are driving Pregabalin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pregabalin API market opportunities vary by end market size?
How does Pregabalin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pregabalin API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pregabalin API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pregabalin API by Country/Region, 2018, 2022 & 2029
2.2 Pregabalin API Segment by Type
2.2.1 Purity ?99%
2.2.2 Purity ?99.5%
2.3 Pregabalin API Sales by Type
2.3.1 Global Pregabalin API Sales Market Share by Type (2018-2023)
2.3.2 Global Pregabalin API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pregabalin API Sale Price by Type (2018-2023)
2.4 Pregabalin API Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Oral Liquid
2.5 Pregabalin API Sales by Application
2.5.1 Global Pregabalin API Sale Market Share by Application (2018-2023)
2.5.2 Global Pregabalin API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pregabalin API Sale Price by Application (2018-2023)
3 GLOBAL PREGABALIN API BY COMPANY
3.1 Global Pregabalin API Breakdown Data by Company
3.1.1 Global Pregabalin API Annual Sales by Company (2018-2023)
3.1.2 Global Pregabalin API Sales Market Share by Company (2018-2023)
3.2 Global Pregabalin API Annual Revenue by Company (2018-2023)
3.2.1 Global Pregabalin API Revenue by Company (2018-2023)
3.2.2 Global Pregabalin API Revenue Market Share by Company (2018-2023)
3.3 Global Pregabalin API Sale Price by Company
3.4 Key Manufacturers Pregabalin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pregabalin API Product Location Distribution
3.4.2 Players Pregabalin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREGABALIN API BY GEOGRAPHIC REGION
4.1 World Historic Pregabalin API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pregabalin API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pregabalin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pregabalin API Market Size by Country/Region (2018-2023)
4.2.1 Global Pregabalin API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pregabalin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pregabalin API Sales Growth
4.4 APAC Pregabalin API Sales Growth
4.5 Europe Pregabalin API Sales Growth
4.6 Middle East & Africa Pregabalin API Sales Growth
5 AMERICAS
5.1 Americas Pregabalin API Sales by Country
5.1.1 Americas Pregabalin API Sales by Country (2018-2023)
5.1.2 Americas Pregabalin API Revenue by Country (2018-2023)
5.2 Americas Pregabalin API Sales by Type
5.3 Americas Pregabalin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pregabalin API Sales by Region
6.1.1 APAC Pregabalin API Sales by Region (2018-2023)
6.1.2 APAC Pregabalin API Revenue by Region (2018-2023)
6.2 APAC Pregabalin API Sales by Type
6.3 APAC Pregabalin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pregabalin API by Country
7.1.1 Europe Pregabalin API Sales by Country (2018-2023)
7.1.2 Europe Pregabalin API Revenue by Country (2018-2023)
7.2 Europe Pregabalin API Sales by Type
7.3 Europe Pregabalin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pregabalin API by Country
8.1.1 Middle East & Africa Pregabalin API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pregabalin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pregabalin API Sales by Type
8.3 Middle East & Africa Pregabalin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pregabalin API
10.3 Manufacturing Process Analysis of Pregabalin API
10.4 Industry Chain Structure of Pregabalin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pregabalin API Distributors
11.3 Pregabalin API Customer
12 WORLD FORECAST REVIEW FOR PREGABALIN API BY GEOGRAPHIC REGION
12.1 Global Pregabalin API Market Size Forecast by Region
12.1.1 Global Pregabalin API Forecast by Region (2024-2029)
12.1.2 Global Pregabalin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pregabalin API Forecast by Type
12.7 Global Pregabalin API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 SUANFARMA
13.1.1 SUANFARMA Company Information
13.1.2 SUANFARMA Pregabalin API Product Portfolios and Specifications
13.1.3 SUANFARMA Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 SUANFARMA Main Business Overview
13.1.5 SUANFARMA Latest Developments
13.2 VASUDHA PHARMA
13.2.1 VASUDHA PHARMA Company Information
13.2.2 VASUDHA PHARMA Pregabalin API Product Portfolios and Specifications
13.2.3 VASUDHA PHARMA Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 VASUDHA PHARMA Main Business Overview
13.2.5 VASUDHA PHARMA Latest Developments
13.3 Atom Pharma
13.3.1 Atom Pharma Company Information
13.3.2 Atom Pharma Pregabalin API Product Portfolios and Specifications
13.3.3 Atom Pharma Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Atom Pharma Main Business Overview
13.3.5 Atom Pharma Latest Developments
13.4 Sienna Biotec
13.4.1 Sienna Biotec Company Information
13.4.2 Sienna Biotec Pregabalin API Product Portfolios and Specifications
13.4.3 Sienna Biotec Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sienna Biotec Main Business Overview
13.4.5 Sienna Biotec Latest Developments
13.5 Kopran
13.5.1 Kopran Company Information
13.5.2 Kopran Pregabalin API Product Portfolios and Specifications
13.5.3 Kopran Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Kopran Main Business Overview
13.5.5 Kopran Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Pregabalin API Product Portfolios and Specifications
13.6.3 Teva Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Afton Pharma
13.7.1 Afton Pharma Company Information
13.7.2 Afton Pharma Pregabalin API Product Portfolios and Specifications
13.7.3 Afton Pharma Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Afton Pharma Main Business Overview
13.7.5 Afton Pharma Latest Developments
13.8 Cadila
13.8.1 Cadila Company Information
13.8.2 Cadila Pregabalin API Product Portfolios and Specifications
13.8.3 Cadila Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cadila Main Business Overview
13.8.5 Cadila Latest Developments
13.9 Sunshine Pharmaceutical
13.9.1 Sunshine Pharmaceutical Company Information
13.9.2 Sunshine Pharmaceutical Pregabalin API Product Portfolios and Specifications
13.9.3 Sunshine Pharmaceutical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sunshine Pharmaceutical Main Business Overview
13.9.5 Sunshine Pharmaceutical Latest Developments
13.10 Hanmi Fine Chemical
13.10.1 Hanmi Fine Chemical Company Information
13.10.2 Hanmi Fine Chemical Pregabalin API Product Portfolios and Specifications
13.10.3 Hanmi Fine Chemical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hanmi Fine Chemical Main Business Overview
13.10.5 Hanmi Fine Chemical Latest Developments
13.11 Rivocean Jiangsu Pharmaceutical
13.11.1 Rivocean Jiangsu Pharmaceutical Company Information
13.11.2 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolios and Specifications
13.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Rivocean Jiangsu Pharmaceutical Main Business Overview
13.11.5 Rivocean Jiangsu Pharmaceutical Latest Developments
13.12 Hubei Vanz Pharm
13.12.1 Hubei Vanz Pharm Company Information
13.12.2 Hubei Vanz Pharm Pregabalin API Product Portfolios and Specifications
13.12.3 Hubei Vanz Pharm Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hubei Vanz Pharm Main Business Overview
13.12.5 Hubei Vanz Pharm Latest Developments
13.13 Menovo
13.13.1 Menovo Company Information
13.13.2 Menovo Pregabalin API Product Portfolios and Specifications
13.13.3 Menovo Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Menovo Main Business Overview
13.13.5 Menovo Latest Developments
13.14 Saintsun
13.14.1 Saintsun Company Information
13.14.2 Saintsun Pregabalin API Product Portfolios and Specifications
13.14.3 Saintsun Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Saintsun Main Business Overview
13.14.5 Saintsun Latest Developments
13.15 SyncoZymes
13.15.1 SyncoZymes Company Information
13.15.2 SyncoZymes Pregabalin API Product Portfolios and Specifications
13.15.3 SyncoZymes Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 SyncoZymes Main Business Overview
13.15.5 SyncoZymes Latest Developments
13.16 Taian Aidi Biotechnology
13.16.1 Taian Aidi Biotechnology Company Information
13.16.2 Taian Aidi Biotechnology Pregabalin API Product Portfolios and Specifications
13.16.3 Taian Aidi Biotechnology Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Taian Aidi Biotechnology Main Business Overview
13.16.5 Taian Aidi Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pregabalin API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pregabalin API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pregabalin API by Country/Region, 2018, 2022 & 2029
2.2 Pregabalin API Segment by Type
2.2.1 Purity ?99%
2.2.2 Purity ?99.5%
2.3 Pregabalin API Sales by Type
2.3.1 Global Pregabalin API Sales Market Share by Type (2018-2023)
2.3.2 Global Pregabalin API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pregabalin API Sale Price by Type (2018-2023)
2.4 Pregabalin API Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Oral Liquid
2.5 Pregabalin API Sales by Application
2.5.1 Global Pregabalin API Sale Market Share by Application (2018-2023)
2.5.2 Global Pregabalin API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pregabalin API Sale Price by Application (2018-2023)
3 GLOBAL PREGABALIN API BY COMPANY
3.1 Global Pregabalin API Breakdown Data by Company
3.1.1 Global Pregabalin API Annual Sales by Company (2018-2023)
3.1.2 Global Pregabalin API Sales Market Share by Company (2018-2023)
3.2 Global Pregabalin API Annual Revenue by Company (2018-2023)
3.2.1 Global Pregabalin API Revenue by Company (2018-2023)
3.2.2 Global Pregabalin API Revenue Market Share by Company (2018-2023)
3.3 Global Pregabalin API Sale Price by Company
3.4 Key Manufacturers Pregabalin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pregabalin API Product Location Distribution
3.4.2 Players Pregabalin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PREGABALIN API BY GEOGRAPHIC REGION
4.1 World Historic Pregabalin API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pregabalin API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pregabalin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pregabalin API Market Size by Country/Region (2018-2023)
4.2.1 Global Pregabalin API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pregabalin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pregabalin API Sales Growth
4.4 APAC Pregabalin API Sales Growth
4.5 Europe Pregabalin API Sales Growth
4.6 Middle East & Africa Pregabalin API Sales Growth
5 AMERICAS
5.1 Americas Pregabalin API Sales by Country
5.1.1 Americas Pregabalin API Sales by Country (2018-2023)
5.1.2 Americas Pregabalin API Revenue by Country (2018-2023)
5.2 Americas Pregabalin API Sales by Type
5.3 Americas Pregabalin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pregabalin API Sales by Region
6.1.1 APAC Pregabalin API Sales by Region (2018-2023)
6.1.2 APAC Pregabalin API Revenue by Region (2018-2023)
6.2 APAC Pregabalin API Sales by Type
6.3 APAC Pregabalin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pregabalin API by Country
7.1.1 Europe Pregabalin API Sales by Country (2018-2023)
7.1.2 Europe Pregabalin API Revenue by Country (2018-2023)
7.2 Europe Pregabalin API Sales by Type
7.3 Europe Pregabalin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pregabalin API by Country
8.1.1 Middle East & Africa Pregabalin API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pregabalin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pregabalin API Sales by Type
8.3 Middle East & Africa Pregabalin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pregabalin API
10.3 Manufacturing Process Analysis of Pregabalin API
10.4 Industry Chain Structure of Pregabalin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pregabalin API Distributors
11.3 Pregabalin API Customer
12 WORLD FORECAST REVIEW FOR PREGABALIN API BY GEOGRAPHIC REGION
12.1 Global Pregabalin API Market Size Forecast by Region
12.1.1 Global Pregabalin API Forecast by Region (2024-2029)
12.1.2 Global Pregabalin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pregabalin API Forecast by Type
12.7 Global Pregabalin API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 SUANFARMA
13.1.1 SUANFARMA Company Information
13.1.2 SUANFARMA Pregabalin API Product Portfolios and Specifications
13.1.3 SUANFARMA Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 SUANFARMA Main Business Overview
13.1.5 SUANFARMA Latest Developments
13.2 VASUDHA PHARMA
13.2.1 VASUDHA PHARMA Company Information
13.2.2 VASUDHA PHARMA Pregabalin API Product Portfolios and Specifications
13.2.3 VASUDHA PHARMA Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 VASUDHA PHARMA Main Business Overview
13.2.5 VASUDHA PHARMA Latest Developments
13.3 Atom Pharma
13.3.1 Atom Pharma Company Information
13.3.2 Atom Pharma Pregabalin API Product Portfolios and Specifications
13.3.3 Atom Pharma Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Atom Pharma Main Business Overview
13.3.5 Atom Pharma Latest Developments
13.4 Sienna Biotec
13.4.1 Sienna Biotec Company Information
13.4.2 Sienna Biotec Pregabalin API Product Portfolios and Specifications
13.4.3 Sienna Biotec Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sienna Biotec Main Business Overview
13.4.5 Sienna Biotec Latest Developments
13.5 Kopran
13.5.1 Kopran Company Information
13.5.2 Kopran Pregabalin API Product Portfolios and Specifications
13.5.3 Kopran Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Kopran Main Business Overview
13.5.5 Kopran Latest Developments
13.6 Teva
13.6.1 Teva Company Information
13.6.2 Teva Pregabalin API Product Portfolios and Specifications
13.6.3 Teva Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Main Business Overview
13.6.5 Teva Latest Developments
13.7 Afton Pharma
13.7.1 Afton Pharma Company Information
13.7.2 Afton Pharma Pregabalin API Product Portfolios and Specifications
13.7.3 Afton Pharma Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Afton Pharma Main Business Overview
13.7.5 Afton Pharma Latest Developments
13.8 Cadila
13.8.1 Cadila Company Information
13.8.2 Cadila Pregabalin API Product Portfolios and Specifications
13.8.3 Cadila Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cadila Main Business Overview
13.8.5 Cadila Latest Developments
13.9 Sunshine Pharmaceutical
13.9.1 Sunshine Pharmaceutical Company Information
13.9.2 Sunshine Pharmaceutical Pregabalin API Product Portfolios and Specifications
13.9.3 Sunshine Pharmaceutical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sunshine Pharmaceutical Main Business Overview
13.9.5 Sunshine Pharmaceutical Latest Developments
13.10 Hanmi Fine Chemical
13.10.1 Hanmi Fine Chemical Company Information
13.10.2 Hanmi Fine Chemical Pregabalin API Product Portfolios and Specifications
13.10.3 Hanmi Fine Chemical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hanmi Fine Chemical Main Business Overview
13.10.5 Hanmi Fine Chemical Latest Developments
13.11 Rivocean Jiangsu Pharmaceutical
13.11.1 Rivocean Jiangsu Pharmaceutical Company Information
13.11.2 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolios and Specifications
13.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Rivocean Jiangsu Pharmaceutical Main Business Overview
13.11.5 Rivocean Jiangsu Pharmaceutical Latest Developments
13.12 Hubei Vanz Pharm
13.12.1 Hubei Vanz Pharm Company Information
13.12.2 Hubei Vanz Pharm Pregabalin API Product Portfolios and Specifications
13.12.3 Hubei Vanz Pharm Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hubei Vanz Pharm Main Business Overview
13.12.5 Hubei Vanz Pharm Latest Developments
13.13 Menovo
13.13.1 Menovo Company Information
13.13.2 Menovo Pregabalin API Product Portfolios and Specifications
13.13.3 Menovo Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Menovo Main Business Overview
13.13.5 Menovo Latest Developments
13.14 Saintsun
13.14.1 Saintsun Company Information
13.14.2 Saintsun Pregabalin API Product Portfolios and Specifications
13.14.3 Saintsun Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Saintsun Main Business Overview
13.14.5 Saintsun Latest Developments
13.15 SyncoZymes
13.15.1 SyncoZymes Company Information
13.15.2 SyncoZymes Pregabalin API Product Portfolios and Specifications
13.15.3 SyncoZymes Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 SyncoZymes Main Business Overview
13.15.5 SyncoZymes Latest Developments
13.16 Taian Aidi Biotechnology
13.16.1 Taian Aidi Biotechnology Company Information
13.16.2 Taian Aidi Biotechnology Pregabalin API Product Portfolios and Specifications
13.16.3 Taian Aidi Biotechnology Pregabalin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Taian Aidi Biotechnology Main Business Overview
13.16.5 Taian Aidi Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pregabalin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pregabalin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ?99%
Table 4. Major Players of Purity ?99.5%
Table 5. Global Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 6. Global Pregabalin API Sales Market Share by Type (2018-2023)
Table 7. Global Pregabalin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pregabalin API Revenue Market Share by Type (2018-2023)
Table 9. Global Pregabalin API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 11. Global Pregabalin API Sales Market Share by Application (2018-2023)
Table 12. Global Pregabalin API Revenue by Application (2018-2023)
Table 13. Global Pregabalin API Revenue Market Share by Application (2018-2023)
Table 14. Global Pregabalin API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Pregabalin API Sales by Company (2018-2023) & (Tons)
Table 16. Global Pregabalin API Sales Market Share by Company (2018-2023)
Table 17. Global Pregabalin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pregabalin API Revenue Market Share by Company (2018-2023)
Table 19. Global Pregabalin API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Pregabalin API Producing Area Distribution and Sales Area
Table 21. Players Pregabalin API Products Offered
Table 22. Pregabalin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pregabalin API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Pregabalin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pregabalin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pregabalin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pregabalin API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Pregabalin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pregabalin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pregabalin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Pregabalin API Sales Market Share by Country (2018-2023)
Table 35. Americas Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pregabalin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Pregabalin API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Pregabalin API Sales Market Share by Region (2018-2023)
Table 41. APAC Pregabalin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pregabalin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Pregabalin API Sales Market Share by Country (2018-2023)
Table 47. Europe Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pregabalin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Pregabalin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pregabalin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Pregabalin API
Table 58. Key Market Challenges & Risks of Pregabalin API
Table 59. Key Industry Trends of Pregabalin API
Table 60. Pregabalin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pregabalin API Distributors List
Table 63. Pregabalin API Customer List
Table 64. Global Pregabalin API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Pregabalin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pregabalin API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Pregabalin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pregabalin API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Pregabalin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pregabalin API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Pregabalin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. SUANFARMA Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 79. SUANFARMA Pregabalin API Product Portfolios and Specifications
Table 80. SUANFARMA Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. SUANFARMA Main Business
Table 82. SUANFARMA Latest Developments
Table 83. VASUDHA PHARMA Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 84. VASUDHA PHARMA Pregabalin API Product Portfolios and Specifications
Table 85. VASUDHA PHARMA Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. VASUDHA PHARMA Main Business
Table 87. VASUDHA PHARMA Latest Developments
Table 88. Atom Pharma Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Atom Pharma Pregabalin API Product Portfolios and Specifications
Table 90. Atom Pharma Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Atom Pharma Main Business
Table 92. Atom Pharma Latest Developments
Table 93. Sienna Biotec Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Sienna Biotec Pregabalin API Product Portfolios and Specifications
Table 95. Sienna Biotec Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Sienna Biotec Main Business
Table 97. Sienna Biotec Latest Developments
Table 98. Kopran Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Kopran Pregabalin API Product Portfolios and Specifications
Table 100. Kopran Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Kopran Main Business
Table 102. Kopran Latest Developments
Table 103. Teva Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pregabalin API Product Portfolios and Specifications
Table 105. Teva Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Teva Main Business
Table 107. Teva Latest Developments
Table 108. Afton Pharma Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 109. Afton Pharma Pregabalin API Product Portfolios and Specifications
Table 110. Afton Pharma Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Afton Pharma Main Business
Table 112. Afton Pharma Latest Developments
Table 113. Cadila Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Cadila Pregabalin API Product Portfolios and Specifications
Table 115. Cadila Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Cadila Main Business
Table 117. Cadila Latest Developments
Table 118. Sunshine Pharmaceutical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Sunshine Pharmaceutical Pregabalin API Product Portfolios and Specifications
Table 120. Sunshine Pharmaceutical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Sunshine Pharmaceutical Main Business
Table 122. Sunshine Pharmaceutical Latest Developments
Table 123. Hanmi Fine Chemical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hanmi Fine Chemical Pregabalin API Product Portfolios and Specifications
Table 125. Hanmi Fine Chemical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hanmi Fine Chemical Main Business
Table 127. Hanmi Fine Chemical Latest Developments
Table 128. Rivocean Jiangsu Pharmaceutical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 129. Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolios and Specifications
Table 130. Rivocean Jiangsu Pharmaceutical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Rivocean Jiangsu Pharmaceutical Main Business
Table 132. Rivocean Jiangsu Pharmaceutical Latest Developments
Table 133. Hubei Vanz Pharm Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hubei Vanz Pharm Pregabalin API Product Portfolios and Specifications
Table 135. Hubei Vanz Pharm Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Hubei Vanz Pharm Main Business
Table 137. Hubei Vanz Pharm Latest Developments
Table 138. Menovo Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 139. Menovo Pregabalin API Product Portfolios and Specifications
Table 140. Menovo Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Menovo Main Business
Table 142. Menovo Latest Developments
Table 143. Saintsun Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 144. Saintsun Pregabalin API Product Portfolios and Specifications
Table 145. Saintsun Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Saintsun Main Business
Table 147. Saintsun Latest Developments
Table 148. SyncoZymes Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 149. SyncoZymes Pregabalin API Product Portfolios and Specifications
Table 150. SyncoZymes Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. SyncoZymes Main Business
Table 152. SyncoZymes Latest Developments
Table 153. Taian Aidi Biotechnology Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 154. Taian Aidi Biotechnology Pregabalin API Product Portfolios and Specifications
Table 155. Taian Aidi Biotechnology Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Taian Aidi Biotechnology Main Business
Table 157. Taian Aidi Biotechnology Latest Developments
Table 1. Pregabalin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pregabalin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity ?99%
Table 4. Major Players of Purity ?99.5%
Table 5. Global Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 6. Global Pregabalin API Sales Market Share by Type (2018-2023)
Table 7. Global Pregabalin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pregabalin API Revenue Market Share by Type (2018-2023)
Table 9. Global Pregabalin API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 11. Global Pregabalin API Sales Market Share by Application (2018-2023)
Table 12. Global Pregabalin API Revenue by Application (2018-2023)
Table 13. Global Pregabalin API Revenue Market Share by Application (2018-2023)
Table 14. Global Pregabalin API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Pregabalin API Sales by Company (2018-2023) & (Tons)
Table 16. Global Pregabalin API Sales Market Share by Company (2018-2023)
Table 17. Global Pregabalin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pregabalin API Revenue Market Share by Company (2018-2023)
Table 19. Global Pregabalin API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Pregabalin API Producing Area Distribution and Sales Area
Table 21. Players Pregabalin API Products Offered
Table 22. Pregabalin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pregabalin API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Pregabalin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pregabalin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pregabalin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pregabalin API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Pregabalin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pregabalin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pregabalin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Pregabalin API Sales Market Share by Country (2018-2023)
Table 35. Americas Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pregabalin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Pregabalin API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Pregabalin API Sales Market Share by Region (2018-2023)
Table 41. APAC Pregabalin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pregabalin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Pregabalin API Sales Market Share by Country (2018-2023)
Table 47. Europe Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pregabalin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Pregabalin API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Pregabalin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pregabalin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pregabalin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pregabalin API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Pregabalin API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Pregabalin API
Table 58. Key Market Challenges & Risks of Pregabalin API
Table 59. Key Industry Trends of Pregabalin API
Table 60. Pregabalin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pregabalin API Distributors List
Table 63. Pregabalin API Customer List
Table 64. Global Pregabalin API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Pregabalin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pregabalin API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Pregabalin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pregabalin API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Pregabalin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pregabalin API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Pregabalin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pregabalin API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Pregabalin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. SUANFARMA Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 79. SUANFARMA Pregabalin API Product Portfolios and Specifications
Table 80. SUANFARMA Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. SUANFARMA Main Business
Table 82. SUANFARMA Latest Developments
Table 83. VASUDHA PHARMA Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 84. VASUDHA PHARMA Pregabalin API Product Portfolios and Specifications
Table 85. VASUDHA PHARMA Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. VASUDHA PHARMA Main Business
Table 87. VASUDHA PHARMA Latest Developments
Table 88. Atom Pharma Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Atom Pharma Pregabalin API Product Portfolios and Specifications
Table 90. Atom Pharma Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Atom Pharma Main Business
Table 92. Atom Pharma Latest Developments
Table 93. Sienna Biotec Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Sienna Biotec Pregabalin API Product Portfolios and Specifications
Table 95. Sienna Biotec Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Sienna Biotec Main Business
Table 97. Sienna Biotec Latest Developments
Table 98. Kopran Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Kopran Pregabalin API Product Portfolios and Specifications
Table 100. Kopran Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Kopran Main Business
Table 102. Kopran Latest Developments
Table 103. Teva Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Pregabalin API Product Portfolios and Specifications
Table 105. Teva Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Teva Main Business
Table 107. Teva Latest Developments
Table 108. Afton Pharma Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 109. Afton Pharma Pregabalin API Product Portfolios and Specifications
Table 110. Afton Pharma Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Afton Pharma Main Business
Table 112. Afton Pharma Latest Developments
Table 113. Cadila Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Cadila Pregabalin API Product Portfolios and Specifications
Table 115. Cadila Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Cadila Main Business
Table 117. Cadila Latest Developments
Table 118. Sunshine Pharmaceutical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Sunshine Pharmaceutical Pregabalin API Product Portfolios and Specifications
Table 120. Sunshine Pharmaceutical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Sunshine Pharmaceutical Main Business
Table 122. Sunshine Pharmaceutical Latest Developments
Table 123. Hanmi Fine Chemical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Hanmi Fine Chemical Pregabalin API Product Portfolios and Specifications
Table 125. Hanmi Fine Chemical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Hanmi Fine Chemical Main Business
Table 127. Hanmi Fine Chemical Latest Developments
Table 128. Rivocean Jiangsu Pharmaceutical Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 129. Rivocean Jiangsu Pharmaceutical Pregabalin API Product Portfolios and Specifications
Table 130. Rivocean Jiangsu Pharmaceutical Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Rivocean Jiangsu Pharmaceutical Main Business
Table 132. Rivocean Jiangsu Pharmaceutical Latest Developments
Table 133. Hubei Vanz Pharm Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 134. Hubei Vanz Pharm Pregabalin API Product Portfolios and Specifications
Table 135. Hubei Vanz Pharm Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Hubei Vanz Pharm Main Business
Table 137. Hubei Vanz Pharm Latest Developments
Table 138. Menovo Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 139. Menovo Pregabalin API Product Portfolios and Specifications
Table 140. Menovo Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Menovo Main Business
Table 142. Menovo Latest Developments
Table 143. Saintsun Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 144. Saintsun Pregabalin API Product Portfolios and Specifications
Table 145. Saintsun Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Saintsun Main Business
Table 147. Saintsun Latest Developments
Table 148. SyncoZymes Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 149. SyncoZymes Pregabalin API Product Portfolios and Specifications
Table 150. SyncoZymes Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. SyncoZymes Main Business
Table 152. SyncoZymes Latest Developments
Table 153. Taian Aidi Biotechnology Basic Information, Pregabalin API Manufacturing Base, Sales Area and Its Competitors
Table 154. Taian Aidi Biotechnology Pregabalin API Product Portfolios and Specifications
Table 155. Taian Aidi Biotechnology Pregabalin API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Taian Aidi Biotechnology Main Business
Table 157. Taian Aidi Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pregabalin API
Figure 2. Pregabalin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pregabalin API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Pregabalin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pregabalin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ?99%
Figure 10. Product Picture of Purity ?99.5%
Figure 11. Global Pregabalin API Sales Market Share by Type in 2022
Figure 12. Global Pregabalin API Revenue Market Share by Type (2018-2023)
Figure 13. Pregabalin API Consumed in Tablet
Figure 14. Global Pregabalin API Market: Tablet (2018-2023) & (Tons)
Figure 15. Pregabalin API Consumed in Capsule
Figure 16. Global Pregabalin API Market: Capsule (2018-2023) & (Tons)
Figure 17. Pregabalin API Consumed in Oral Liquid
Figure 18. Global Pregabalin API Market: Oral Liquid (2018-2023) & (Tons)
Figure 19. Global Pregabalin API Sales Market Share by Application (2022)
Figure 20. Global Pregabalin API Revenue Market Share by Application in 2022
Figure 21. Pregabalin API Sales Market by Company in 2022 (Tons)
Figure 22. Global Pregabalin API Sales Market Share by Company in 2022
Figure 23. Pregabalin API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pregabalin API Revenue Market Share by Company in 2022
Figure 25. Global Pregabalin API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pregabalin API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pregabalin API Sales 2018-2023 (Tons)
Figure 28. Americas Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pregabalin API Sales 2018-2023 (Tons)
Figure 30. APAC Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pregabalin API Sales 2018-2023 (Tons)
Figure 32. Europe Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pregabalin API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pregabalin API Sales Market Share by Country in 2022
Figure 36. Americas Pregabalin API Revenue Market Share by Country in 2022
Figure 37. Americas Pregabalin API Sales Market Share by Type (2018-2023)
Figure 38. Americas Pregabalin API Sales Market Share by Application (2018-2023)
Figure 39. United States Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pregabalin API Sales Market Share by Region in 2022
Figure 44. APAC Pregabalin API Revenue Market Share by Regions in 2022
Figure 45. APAC Pregabalin API Sales Market Share by Type (2018-2023)
Figure 46. APAC Pregabalin API Sales Market Share by Application (2018-2023)
Figure 47. China Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pregabalin API Sales Market Share by Country in 2022
Figure 55. Europe Pregabalin API Revenue Market Share by Country in 2022
Figure 56. Europe Pregabalin API Sales Market Share by Type (2018-2023)
Figure 57. Europe Pregabalin API Sales Market Share by Application (2018-2023)
Figure 58. Germany Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pregabalin API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pregabalin API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pregabalin API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pregabalin API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pregabalin API in 2022
Figure 73. Manufacturing Process Analysis of Pregabalin API
Figure 74. Industry Chain Structure of Pregabalin API
Figure 75. Channels of Distribution
Figure 76. Global Pregabalin API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pregabalin API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pregabalin API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pregabalin API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pregabalin API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pregabalin API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pregabalin API
Figure 2. Pregabalin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pregabalin API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Pregabalin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pregabalin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity ?99%
Figure 10. Product Picture of Purity ?99.5%
Figure 11. Global Pregabalin API Sales Market Share by Type in 2022
Figure 12. Global Pregabalin API Revenue Market Share by Type (2018-2023)
Figure 13. Pregabalin API Consumed in Tablet
Figure 14. Global Pregabalin API Market: Tablet (2018-2023) & (Tons)
Figure 15. Pregabalin API Consumed in Capsule
Figure 16. Global Pregabalin API Market: Capsule (2018-2023) & (Tons)
Figure 17. Pregabalin API Consumed in Oral Liquid
Figure 18. Global Pregabalin API Market: Oral Liquid (2018-2023) & (Tons)
Figure 19. Global Pregabalin API Sales Market Share by Application (2022)
Figure 20. Global Pregabalin API Revenue Market Share by Application in 2022
Figure 21. Pregabalin API Sales Market by Company in 2022 (Tons)
Figure 22. Global Pregabalin API Sales Market Share by Company in 2022
Figure 23. Pregabalin API Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pregabalin API Revenue Market Share by Company in 2022
Figure 25. Global Pregabalin API Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pregabalin API Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pregabalin API Sales 2018-2023 (Tons)
Figure 28. Americas Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pregabalin API Sales 2018-2023 (Tons)
Figure 30. APAC Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pregabalin API Sales 2018-2023 (Tons)
Figure 32. Europe Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pregabalin API Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Pregabalin API Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pregabalin API Sales Market Share by Country in 2022
Figure 36. Americas Pregabalin API Revenue Market Share by Country in 2022
Figure 37. Americas Pregabalin API Sales Market Share by Type (2018-2023)
Figure 38. Americas Pregabalin API Sales Market Share by Application (2018-2023)
Figure 39. United States Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pregabalin API Sales Market Share by Region in 2022
Figure 44. APAC Pregabalin API Revenue Market Share by Regions in 2022
Figure 45. APAC Pregabalin API Sales Market Share by Type (2018-2023)
Figure 46. APAC Pregabalin API Sales Market Share by Application (2018-2023)
Figure 47. China Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pregabalin API Sales Market Share by Country in 2022
Figure 55. Europe Pregabalin API Revenue Market Share by Country in 2022
Figure 56. Europe Pregabalin API Sales Market Share by Type (2018-2023)
Figure 57. Europe Pregabalin API Sales Market Share by Application (2018-2023)
Figure 58. Germany Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pregabalin API Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pregabalin API Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pregabalin API Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pregabalin API Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pregabalin API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pregabalin API in 2022
Figure 73. Manufacturing Process Analysis of Pregabalin API
Figure 74. Industry Chain Structure of Pregabalin API
Figure 75. Channels of Distribution
Figure 76. Global Pregabalin API Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pregabalin API Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pregabalin API Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pregabalin API Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pregabalin API Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pregabalin API Revenue Market Share Forecast by Application (2024-2029)
